Guodong Li
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
-
- Circular RNAs in diseases 3
- Oncology 13
- Drug Transport and Resistance Mechanisms 6
- Co-authors
- Grace L. Guo (11 shared papers)Ru Wei (1 shared paper)Albert Seymour (1 shared paper)Shuwei Dang (8 shared papers)Jiufeng Wei (7 shared papers)Lixian Ding (7 shared papers)Stewart A. Metz (3 shared papers)Hongsheng Chen (4 shared papers)
- Journals
- Toxicology and Applied Pharmacology (3 papers)PLoS ONE (3 papers)Oncology Reports (2 papers)American Journal of Physiology-Gastrointestinal and Liver Physiology (2 papers)International Journal of Oncology (2 papers)
- Partner nations
- ChinaUnited StatesNetherlands
In The Last Decade
Guodong Li
55 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 110
- Cancer Research 369
- Applied Microbiology and Biotechnology 29
- Molecular Biology 997
- Hepatology 84
- Pharmaceutical Science 72
Countries citing papers authored by Guodong Li
This map shows the geographic impact of Guodong Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guodong Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guodong Li more than expected).
Fields of papers citing papers by Guodong Li
This network shows the impact of papers produced by Guodong Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guodong Li. The network helps show where Guodong Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Guodong Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 56 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 200 | |
| 2 | 2010 | 176 | |
| 3 | 2015 | 108 | |
| 4 | 2008 | 95 | |
| 5 | 2014 | 89 | |
| 6 | 2010 | 82 | |
| 7 | 2021 | 69 | |
| 8 | 2015 | 60 | |
| 9 | 2011 | 59 | |
| 10 | 1998 | 57 | |
| 11 | 2024 | 55 | |
| 12 | 2021 | 55 | |
| 13 | 1993 | 44 | |
| 14 | 2013 | 44 | |
| 15 | 2016 | 43 | |
| 16 | 2010 | 42 | |
| 17 | 2015 | 40 | |
| 18 | 2012 | 36 | |
| 19 | 2017 | 36 | |
| 20 | 2006 | 33 |
About Guodong Li
Guodong Li is a scholar working on Molecular Biology, Oncology, Cell Biology, Cancer Research and Surgery, having authored 56 papers that have together received 1.9k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (6 papers), Cancer-related molecular mechanisms research (5 papers), Ferroptosis and cancer prognosis (4 papers), Cancer, Lipids, and Metabolism (4 papers), Liver physiology and pathology (3 papers), Pomegranate: compositions and health benefits (3 papers), Liver Disease Diagnosis and Treatment (3 papers) and Circular RNAs in diseases (3 papers). The work is most often cited by research in Cancer Research (369 citations), Applied Microbiology and Biotechnology (29 citations), Molecular Biology (997 citations), Hepatology (84 citations) and Pharmaceutical Science (72 citations). Guodong Li has collaborated with scholars based in China, United States and Netherlands. Frequent co-authors include Grace L. Guo, Ru Wei, Albert Seymour, Shuwei Dang, Jiufeng Wei, Lixian Ding, Stewart A. Metz, Hongsheng Chen, Bo Kong and Jessica A. Williams. Their work appears in journals such as Toxicology and Applied Pharmacology, PLoS ONE, Oncology Reports, American Journal of Physiology-Gastrointestinal and Liver Physiology and International Journal of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.